News Blow for Lilly after FDA panel uncertain over RA drug bariti... Doubts over marketability of drug if it is approved
News UK pharma calls for cooperation as EMA continues Brexit spli... Britain’s pharma trade body has issued a fresh Brexit warning, saying it would be disadvantageous to both the UK and the EU if drugs regulation diverges as a result of the political changes
News Pacira CEO hopes for further expansion to US nerve block lab... CEO wants "broad nerve block label" for Exparel
Events Partner Content 9th Annual Biologics Formulation Development and Drug Delive... Formulation development for Safe Delivery to patient
News Lilly's 'triple G' retatrutide aces crucial obesity trial Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
